Moreover, TGP could improve other outcomes related to SLE disease activity, including complement proteins (C3 and C4), immunoglobulins (IgA, IgM and, IgG), ESR, CRP, 24 h urine protein, and recurrence rate [117]. The gene discussed is CD79A; the disease is systemic lupus erythematosus.